Catalyst Wire Dossier Catalyst Wire Dossier

Ozanezumab

ozanezumab · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ozanezumab, covering 2017-04-19 to 2017-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]

See pricing